Search

everythinglearnresearchcommunity

for

Search:↓

Telogen Effluvium causes increased hair shedding and can be challenging to diagnose and treat.

Wheat extract supplements reduce hair shedding and improve growth in women with hair loss.

People with chronic hair shedding have lower antioxidant levels in their blood compared to healthy individuals.

Acute telogen effluvium can be resolved by addressing causes, but chronic telogen effluvium is harder to treat.

Ultrasound and laser technologies improve drug delivery through the skin by enhancing penetration and control.

Skin has a larger surface area than thought, certain skin cells improve skin flap survival, better trials for skin conditions in children are needed, Stevens-Johnson syndrome rates vary by age and race, and better skin barrier function may reduce inflammation in the elderly.

Most women in the study lost hair due to chronic shedding, with stress and nutrient deficiencies being common factors.

The new dressing speeds up wound healing better than current options.

Loss of a specific protein in skin cells causes symptoms similar to psoriasis.

Lecithin microemulsion safely delivers tetracaine hydrochloride through the skin.

The study found that long-term sun exposure does not significantly affect follicular plugs on the scalp, and the scalp's appearance is unique compared to other body parts.

Electromagnetic energy from wound dressing paste can disrupt skin lipid droplets, possibly affecting cancer development.

Hair removal methods damage the skin barrier and affect substance penetration.

A new method for delivering drugs through the skin using biodegradable particles was found to be effective.

Transgender individuals face unique skin issues, often due to hormone therapy, requiring specialized and stigma-free dermatologic care.

Transdermal delivery systems show promise for treating hair loss by delivering drugs directly through the skin.

Telogen Effluvium is a hair loss condition where treatment involves identifying and managing its triggers.

Skin ages and changes due to sun, wind, and aging, causing dryness, thinning, and hair loss.

A woman lost all her hair in one day, was diagnosed with a rare type of hair loss, and regrew it in 12 weeks with treatment.

RV3466F lotion significantly reduces hair loss and improves acute telogen effluvium.

Patients with certain skin diseases are willing to spend significant time on treatment, indicating a high impact on their lives and a need for better treatments.

Transcutol-containing vesicles improve minoxidil's skin penetration and hair growth promotion.

Women with telogen effluvium have an imbalance in thiol-disulphide, suggesting oxidative stress may contribute to hair loss.

The pull and wash tests are simple, cost-effective ways to diagnose hair loss severity and type.

Hydrocolloid wound dressings emit energy that can affect human hair follicle metabolism.

Emotional stress can trigger intermittent hair loss in chronic telogen effluvium, which may not improve with treatment if stress continues.

The TLMG hydrogel improves wound healing and monitoring with strong adhesion and conductivity.

A rare hair follicle disorder can cause itchy, bluish-black bumps on the body.

The Unani System of Medicine offers treatments for managing diffuse hair loss caused by stress and nutritional deficiencies.

Active transdermal technologies in cosmetics help deliver skin treatments effectively, but their safety and effectiveness depend on skin type and treatment choice.